STAASTAAR Surgical Company
Is the price fair?
Cheap against its own history. That is the only one of 3 checks this filer's data supports, so take it as a single data point rather than a settled answer.
Cheap vs its own history: P/E 84.6 vs a 107.9 median over 16 quarters (−22% vs median).
Against the whole market›
Percentile against every name Ryufin tracks. Higher is better; the tick marks the middle of the market. Context, not one of the checks above.
Where this answer is blind. The growth-implied estimate assumes a fixed discount rate; capital-heavy sectors look structurally rich on it.
What STAA's price assumes
STAAR Surgical Company trades at 271× earnings against 39.6× for the median Medical Instruments & Supplies name, more expensive than its own group.
Trailing P/E · Medical Instruments & Supplies median 39.6 · 6.84× the median: the market pays up for this one
- Price / sales
- 6.49
Price / sales · today's price, fiscal year to Jan 2, 2026
- Price / book
- 4.51
Price / book · today's price, fiscal year to Jan 2, 2026
- EV / sales
- 5.71
EV / sales
Details›
- Price / booktoday's price, fiscal year to Jan 2, 2026
- 4.51
- EV / salestoday's price, fiscal year to Jan 2, 2026
- 5.71
- Healthcare median P/E509 names
- 26.2
- Medical Instruments & Supplies median P/E33 names
- 39.6
- Market capitalisation
- $1.55B
| Method | Per share |
|---|---|
| Its own P/E history, lower quartile | $7.76 |
| Its own P/E history, median | $8.63 |
| Its own P/E history, upper quartile | $11.13 |
| 52-week range | $16.10 – $33.34 |
| Today | $21.68 |
Multiples from SEC filings and end-of-day closes; implied growth from a reverse discounted cash flow. Group medians across the names Ryufin tracks.
Medical Instruments & Supplies
Ranks #9 of 21 by RyuScore